InferX Corporation and Funding Profiles Announce Beta Availability of New Autosense 1.0 Predictive Analytics Solution for Fortune 500 Clients

TYSONS CORNER, Va., Sept. 30, 2013 (GLOBE NEWSWIRE) -- InferX Corporation (OTC/PK:NFRX) and Funding Profiles announced the early adopter program for Autosense 1.0, a new predictive analytics product to provide Fortune 500 firms with a powerful new tool to improve performance and minimize risk. The Autosense 1.0 product integrates InferX's proprietary real time predictive analytics technology with Funding Profiles' powerful analytic and financial visualization tools, primarily targeting financial planning and analysis staff in Fortune 500 organizations. The emerging product enables companies to assess how well a client's strategic plan relates to the client's revenue segments, global costs, product segmentation, market sectors, target global markets, technology stratification, and other specialized risk factors based on individual client profiles and needs.

The initial Autosense 1.0 beta release will be demonstrated at an upcoming Funding Profiles Product Advisory Council with key finance executives in Santa Clara, CA on October 15, 2013 to secure feedback for continued product development. A commercial product launch is planned in mid-2014.

The ability to improve predictions in sales forecasts across thousands of global products, assess budget impact due to external regional market factors worldwide, and optimize program portfolios based on risk-adjusted business metrics are among the many new powerful capabilities offered to management with easy-to-use visualization tools. The product also integrates updated financial and performance data, "learns" based on actual performance, and optimizes business rules and metrics based on actual performance.

"While we have seen many management analytic solutions emerge addressing CRM, supply chain management, and other operational areas, using advanced analytics to address finance and strategy management, understanding how portfolios perform and meet strategic objectives is an exciting new management analytics arena," said Paul B. Silverman, InferX CEO and President. "Today's initial Autosense product release is a first step in creating powerful new management tools, business rather than technology-driven, to help Fortune 500 firms improve performance and mitigate risk in today's big data-driven, hypercompetitive, complex, high risk global markets," said Silverman.

"The InferX team has proven to us that InferX's powerful suite of predictive analytics solutions can be applied to improving forecasts and understanding the likelihood of investment success," said Madison Laird, Funding Profiles' Chairman and CEO." Our industry advisors have already told us that they have considerable interest in improving performance in these areas by using Big Data analytics coupled with powerful, easy-to-use visualization tools," said Laird.

About Funding Profiles

Funding Profiles makes solutions for finance departments that want to contribute to an enterprise's strategy beyond just numbers. Funding Profiles solutions integrate with existing business applications and data sources to continuously translate traditional financial metrics into the language of business strategy. Using solutions from Funding Profiles, finance teams can express plans, targets, actuals, forecasts, or scenarios in strategic perspectives any business leader can appreciate. Funding Profiles is based in Sunnyvale, California, and has locations in Seattle, Philadelphia, and Washington D.C. For more information, visit the Company's website

About InferX Corporation

InferX is a market leader in next generation distributed Predictive Analytics and Business Intelligence Products and Solutions. InferX has pioneered and commercialized a powerful, patented suite of advanced data analytical solutions that improve corporate performance across the enterprise in the healthcare, financial services, and government markets. The Company has two patents issued for its real time, distributed predictive analytics and business intelligence system. InferX is uniquely capable of delivering secure, real-time, and privacy preserving intelligence and decision support — all without the need to move data. InferX is headquartered in Tysons Corner, VA. For more information, visit the InferX website

Forward-Looking Statements

Certain statements above, in press releases and NFRX officials oral statements are "Forward-Looking Statements" (FLS) according to the Private Securities Litigation Reform Act of 1995 (the "Act"). FLS include statements predictive in nature, depending upon or referring to future events / conditions, including words like "believes," "anticipates," "intends," "plans," "expects," and similar expressions. Statements concerning future financial performance (revenues, earnings, and growth rates), ongoing business strategies / prospects, and future actions, which may be provided by management, are also FLS as defined by the Act. The actual and any future results, performance or achievements of the Company, expressed or implied, may be materially different and vary significantly for different reporting periods due to FLS that involve known and unknown risks and other factors. See InferX's 10-K for 12/31/11 for a discussion of those risks. Management believes that the assumptions made and expectations reflected in the FLS are reasonable. There is no assurance that the underlying assumptions will prove to be correct and the actual future results may be different from expectations expressed above. These statements are not guarantees of future performance. NFRX has no specific intention to update these statements.

©2011 InferX Corporation. All rights reserved. All trademarks and company names mentioned are the property of their respective owners.

CONTACT: InferX Corporation Tel 703-850-5697 Fax 703-444-2119 (OTCPK: NFRX) 1934 Old Gallows Road Suite 400 Tysons Corner, VA 22182 Investor Relations:, Inc. Phone: (512) 267-2430 Fax: (512) 267-2530 Email: Funding Profiles Scott Gripenstraw (408) 498-5840 x104Source:InferX Corporation